Expert Interview
Examining the potential of Anavex' blarcamesine in Rett Syndrome with a focus on the recent data from the P3 AVATAR trial
Ticker(s): AVXLInstitution: Boston Children's Hospital
- Pediatric Neurologist & Director of the Comprehensive Rett Syndrome Program at Boston Children’s Hospital, one of 18 IRSF designated Centers of Excellence.
- Sees over 100 patients with Rett syndrome and Rett-related disorders each year.
- Principle Investigator for the Phase 2 study of blarcamesine in adult women with Rett syndrome.
Can you please describe your clinical practice?
Added By: sara_adminWhat were your initial thought and key take aways from the data presented in the AVATAR Phase 3 trial of ANAVEX 2-73?
Added By: sara_adminDo you have any insight into the other indications for which ANAVEX 2-71 is being investigated as a potential treatment?
Added By: sara_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
